ALK-positive Non-small Cell Lung Cancer (NSCLC)
specificA group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.
9
Centers
0
Active Trials
—
Cancer Funding
Top Centers for ALK-positive Non-small Cell Lung Cancer (NSCLC)(9)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 55.6 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 55.6 |
| 3 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 55.6 |
| 4 | Duke Cancer InstituteDurham, NC NCI Comprehensive | 55.6 |
| 5 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 55.6 |
| 6 | University of Illinois Cancer CenterChicago, IL | 55.6 |
| 7 | Boston University Cancer CenterBoston, MA | 55.6 |
| 8 | BC CancerVancouver, BC | 55.6 |
| 9 | Princess Margaret Cancer CentreToronto, ON | 55.6 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →